114 related articles for article (PubMed ID: 2321268)
1. Sensitization of chronic myeloid leukemia cells to adriamycin cytotoxicity by clofibrate.
Parekh H; Satyamoorthy K; Advani S; Chitnis M
Tumori; 1990 Feb; 76(1):18-21. PubMed ID: 2321268
[TBL] [Abstract][Full Text] [Related]
2. Differential alteration of cellular lipids in drug sensitive and resistant P388 leukemia cells by clofibrate: effects on mitoxantrone cytotoxicity.
Parekh H; Chitnis M
Tumori; 1991 Apr; 77(2):105-11. PubMed ID: 2048221
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of clofibrate on adriamycin cytotoxicity in P388 murine leukemia cells sensitive and resistant to adriamycin.
Chitnis M; Parekh H; Satyamoorthy K
Tumori; 1989 Apr; 75(2):100-5. PubMed ID: 2741213
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of human chronic myeloid leukemia cells insensitivity to adriamycin and mitoxanthrone cytotoxicity by quinidine.
Parekh HK; Advani SH; Chitnis MP
Neoplasma; 1990; 37(6):717-25. PubMed ID: 2274089
[TBL] [Abstract][Full Text] [Related]
5. Bepridil enhances adriamycin-induced DNA biosynthesis inhibition in human myeloid leukemia cells.
Parekh H; Advani S; Chitnis M
Sel Cancer Ther; 1990; 6(4):183-91. PubMed ID: 2094938
[TBL] [Abstract][Full Text] [Related]
6. Dipyrone enhances intracellular accumulation and cytotoxicity of adriamycin in human chronic myeloid leukemia cells.
Chitnis MP; Kamath NS; Parekh HK; Advani SH
Neoplasma; 1991; 38(2):185-91. PubMed ID: 2041578
[TBL] [Abstract][Full Text] [Related]
7. Single and combination treatment with vitamin K3 and adriamycin: in vitro effects on cell survival and DNA damage in human chronic myeloid leukemia cells.
Parekh H; Chavan S; Advani S; Chitnis M
Sel Cancer Ther; 1991; 7(3):127-35. PubMed ID: 1771299
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone & adriamycin cytotoxicity enhanced by reserpine in human chronic myeloid leukaemia cells.
Chitnis MP; Kamath NS; Advani SH
Indian J Med Res; 1989 Jun; 90():197-202. PubMed ID: 2767744
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of doxorubicin resistance by pentoxifylline in human chronic myeloid leukemia cells in vitro.
Viladkar A; Juvekar A; Chitnis M; Advani S
Sel Cancer Ther; 1991; 7(3):119-26. PubMed ID: 1771298
[TBL] [Abstract][Full Text] [Related]
10. Response of human chronic myeloid leukemia cells to mitoxantrone cytotoxicity: potentiation by bepridil, a calcium channel antagonist.
Parekh HK; Shallom JM; Advani SH; Chitnis MP
Neoplasma; 1991; 38(6):575-81. PubMed ID: 1766484
[TBL] [Abstract][Full Text] [Related]
11. Modulation of mitoxantrone cytotoxicity by verapamil in human chronic myeloid leukemia cells.
Satyamoorthy K; Chitnis MP; Pradhan SG; Advani SH
Oncology; 1989; 46(2):128-31. PubMed ID: 2710477
[TBL] [Abstract][Full Text] [Related]
12. Modulation of sensitivity to mitoxantrone in human chronic myeloid leukemia cells by the antidepressant sintamil.
Chitnis MP; Satyamoorthy K; Pradhan SG; Advani SH
Oncology; 1988; 45(4):292-6. PubMed ID: 3164462
[TBL] [Abstract][Full Text] [Related]
13. Costunolide enhances sensitivity of K562/ADR chronic myeloid leukemia cells to doxorubicin through PI3K/Akt pathway.
Cai H; Li L; Jiang J; Zhao C; Yang C
Phytother Res; 2019 Jun; 33(6):1683-1688. PubMed ID: 30937974
[TBL] [Abstract][Full Text] [Related]
14. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J
Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976
[TBL] [Abstract][Full Text] [Related]
15. Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro.
Mow BM; Chandra J; Svingen PA; Hallgren CG; Weisberg E; Kottke TJ; Narayanan VL; Litzow MR; Griffin JD; Sausville EA; Tefferi A; Kaufmann SH
Blood; 2002 Jan; 99(2):664-71. PubMed ID: 11781252
[TBL] [Abstract][Full Text] [Related]
16. Modulation of in vitro response to adriamycin by verapamil in murine P388 leukaemia, Ehrlich ascites carcinoma and sarcoma 180.
Pradhan SG; Chitnis MP; Basrur VS; Tantri SK
Eur J Cancer Clin Oncol; 1987 Apr; 23(4):437-42. PubMed ID: 3609108
[TBL] [Abstract][Full Text] [Related]
17. In vitro enhancement of adriamycin cytotoxicity in human myeloid leukemia cells exposed to verapamil.
Pradhan SG; Basrur VS; Chitnis MP; Adwani SH
Oncology; 1984; 41(6):406-8. PubMed ID: 6594649
[TBL] [Abstract][Full Text] [Related]
18. In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia.
La Rosée P; Johnson K; O'Dwyer ME; Druker BJ
Exp Hematol; 2002 Jul; 30(7):729-37. PubMed ID: 12135670
[TBL] [Abstract][Full Text] [Related]
19. Alterations of membrane fluidity in K562 cells exposed to the anticancer drug adriamycin.
Marutaka M; Iwagaki H; Suguri T; Tanaka N; Orita K
Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):163-70. PubMed ID: 7994561
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells.
Parekh H; Chitnis M
Sel Cancer Ther; 1990; 6(2):93-102. PubMed ID: 2367755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
